IMPORTANT SAFETY INFORMATION: alloClae™ is intended to be applied subcutaneously in localized areas of the body to provide cushioning and support to the patient's body where adipose tissue naturally exists. alloClae™ does not contain viable cells, and has no systemic effect, and is not dependent upon the metabolic activity of living cells for its primary function. This allograft is intended for single patient use only. Human tissue shall not be offered or dispensed for veterinary use. alloClae™ should not be used on patients with severe allergen sensitivities, a history of anaphylaxis, or in the presence of active infection. Like all procedures of this type there is a possibility of complications, although not everyone experiences them. Those potential complications include cystic or nodule formations, pain or infection, hematoma, anaphylaxis or other allergic or immune responses, or discoloration of the skin at the procedure site.
